Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024. In the quarter to June 2026, revenue grew 8.80%, EPS grew 42.8% and free cash flow fell 43.5%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years, revenue growth for three.

512.38 3.06 −0.59%
Market cap
$6.7B
P/E
25.7×
Fwd P/E
20.4×
Dividend yield
0.49%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
2,529.98 2,431.29 2,264.42 2,134.96 2,139.26 2,079.58 1,938.56 1,782.65 1,666.72 1,576.88
Revenue Growth
4.06% 7.37% 6.06% (0.20%) 2.87% 7.27% 8.75% 6.96% 5.70% 2.17%
Gross Profit
823.18 854.35 798.81 765.09 769.80 701.39 617.43 555.00 516.19 461.45
Operating Income
338.25 366.49 340.57 343.50 343.04 389.68 257.38 243.63 113.04 178.75
EBT
355.78 399.47 350.37 329.68 350.31 395.99 261.61 239.60 116.92 177.05
Income after Tax
265.24 302.00 272.51 249.62 268.55 319.47 219.92 205.54 98.18 108.74
Net Income Common
265.24 302.00 272.51 249.62 268.55 319.47 219.92 205.54 98.18 108.74
EPS (Diluted)
18.34 19.89 17.93 16.53 16.85 19.48 13.31 12.23 5.86 6.48
Shares (Diluted, Weighted)
14.46 15.19 15.20 15.10 15.94 16.40 16.53 16.80 16.74 16.79
Gross Margin
32.54% 35.14% 35.28% 35.84% 35.98% 33.73% 31.85% 31.13% 30.97% 29.26%
EBIT Margin
13.37% 15.07% 15.04% 16.09% 16.04% 18.74% 13.28% 13.67% 6.78% 11.34%
Net Profit Margin
10.48% 12.42% 12.03% 11.69% 12.55% 15.36% 11.34% 11.53% 5.89% 6.90%
Free Cash Flow Margin
13.05% 15.27% 12.10% 11.94% 11.72% 20.78% 12.80% 13.14% 5.89% 6.06%
EBITDA
403.41 429.86 402.01 403.01 402.39 446.57 302.89 283.38 150.41 215.76
EBIT
338.25 366.49 340.57 343.50 343.04 389.68 257.38 243.63 113.04 178.75

Show all line items

In millions of $ except per-share values · columns are period end dates